Men Prostate
Natural health product licensed in Canada
- Licence holder
- Jensens Labs Inc.
- NPN or DIN-HM
- 80084504
- Status
- Active licence
- Licence date
- 16 April 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Curcuma longa Source : Rhizome | 1,000 mg | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 1:1 Dry plant equivalent : 1 g | 1 mL | Not calculated |
| Solanum lycopersicum Source : Chair (fruit) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg Potency : 10 % Lycopene | 100 mg | Not calculated |
| Vaccinium macrocarpon Source : Fruit Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 5,000 mg | 200 mg | Not calculated |
| Cucurbita pepo Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 160 mg | 40 mg | Not calculated |
| Prunus africana Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 mg Potency : 13 % Phytosterols | 100 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Dioxyde de titane, Stéarate de magnésium, Gel de silice, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Helps reduce the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with benign prostatic hyperplasia. Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Provides antioxidants for the maintenance of good health. Helps to support prostate health. (Traditionally) used in Herbal Medicine to help prevent (recurrent) urinary tract infections (UTIs). Provides antioxidants for the maintenance of good health. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use: to exclude a diagnosis of prostate cancer; if you have gallstones or a bile duct obstruction; if you have stomach ulcers or excess stomach acid; if you are taking blood thinners; if you have a history of kidney stones. Consult a healthcare practitioner if symptoms persist or worsen.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80084504
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.